Analyzing and predicting the LNM rate and prognosis of patients with intraductal papillary mucinous neoplasm of the pancreas
Open Access
- 27 February 2021
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 10 (6) , 1925-1935
Abstract
Background Current the surveillance and management are controversial for patients with IPMN. We aimed to develop an alternative nomogram to individualize IPMN prognosis and LNM. Methods Based on the data from SEER database of patients diagnosed with IPMN between 2004 and 2015, a nomogram predicting the survival and LNM of IPMN based on univariate and multivariate and Lasso regression analysis was performed, internally and externally validated, and measured by C‐index, and decision curve analysis (DCA), and compared to the 7th TNM stage. Results A total of 941 patients were included. Age, T stage examined nodes, tumor size, and pathology grade were identified as an independent factor for predicting LNM. The nomogram we established to predict LNM had a high predicting value with a C‐index value of 0.735 and an AUC value of 0.753. Interestingly, including T1 stage, we found an inverse correlation was between age and LNM. In addition, nomogram for predicting CSS also performed better than TNM stage both in the internal validation group (1‐year AUC:0.753 vs. 0.693, 3‐year AUC: 0.801 vs. 0.731, 5‐year AUC: 0.803 vs. 0.733) and external validation group (1‐year AUC: 0.761 vs. 0.701, 3‐year AUC: 0.772 vs. 0.713, 5‐year AUC:0.811 vs. 0.735). DCA analysis showed the nomogram showed a greater benefit across the period of follow‐up compared to 7th TNM stage. Conclusion A nomogram based on multivariate and Lasso regression analysis showed great clinical usability compared with current criteria. Also, for LNM of IPMN, younger age patients with IPMN should be attached more importance.Keywords
Funding Information
- National Natural Science Foundation of China (81560398, 81660404, 82060448)
This publication has 31 references indexed in Scilit:
- The Clinical Indications for Limited Surgery of Intraductal Papillary Mucinous Neoplasms of the PancreasWorld Journal of Surgery, 2016
- A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the PancreasAmerican Journal of Surgical Pathology, 2015
- The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN)Cancer, 2015
- Risk factors for postoperative recurrence of intraductal papillary mucinous neoplasms of the pancreas based on a long‐term follow‐up study: proposals for follow‐up strategiesJournal of Hepato-Biliary-Pancreatic Sciences, 2015
- American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Asymptomatic Neoplastic Pancreatic CystsGastroenterology, 2015
- Surgical treatment and prognosis of 96 cases of intraductal papillary mucinous neoplasms of the pancreas: A retrospective cohort studyInternational Journal of Surgery, 2015
- Adjuvant chemotherapy seems beneficial for invasive intraductal papillary mucinous neoplasmsEuropean Journal of Surgical Oncology, 2013
- International consensus guidelines 2012 for the management of IPMN and MCN of the pancreasPancreatology, 2012
- How To Build and Interpret a Nomogram for Cancer PrognosisJournal of Clinical Oncology, 2008
- Incidence of Additional Primary Cancers in Patients with Invasive Intraductal Papillary Mucinous Neoplasms and Sporadic Pancreatic AdenocarcinomasJournal of the American College of Surgeons, 2007